Literature DB >> 2563338

Percutaneous transluminal angioplasty for innominate artery stenosis and total occlusion of subclavian artery in Takayasu's-type arteritis.

B J Staller1, M Maleki.   

Abstract

Previous reports describe high success rates achieved by dilating subclavian artery stenoses. Attempts at angioplasty for total occlusions have been uniformly unsuccessful. No previous case successfully recanalizing total subclavian artery occlusion was found after an extensive literature search. Modified guidewire technique facilitated safe crossing of the occlusion.

Entities:  

Keywords:  Americas; Arterial Occlusive Diseases; Arteriosclerosis; Asians; Atherosclerosis; Behavior; Biology; Case Studies; Catheter; Cholesterol; Contraception; Contraceptive Methods--side effects; Cultural Background; Demographic Factors; Developed Countries; Diabetes Mellitus; Diseases; Equipment And Supplies; Ethnic Groups; Examinations And Diagnoses; Family Planning; Follow-up Studies; Heart Diseases; Hypertension; Laboratory Examinations And Diagnoses; Lipids; North America; Northern America; Oral Contraceptives--side effects; Physiology; Population; Population Characteristics; Research Methodology; Risk Factors; Signs And Symptoms; Smoking--complications; Studies; United States; Vascular Diseases; Vertigo; Wisconsin

Mesh:

Substances:

Year:  1989        PMID: 2563338     DOI: 10.1002/ccd.1810160204

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  2 in total

1.  Outcomes after endovascular treatment of symptomatic patients with Takayasu's arteritis.

Authors:  H J Kim; C-S Lee; J S Kim; S U Know; J L Kim; J W Park; D H Hyun; D C Suh
Journal:  Interv Neuroradiol       Date:  2011-06-20       Impact factor: 1.610

2.  Percutaneous transluminal angioplasty for occlusion of the subclavian artery: short- and long-term results.

Authors:  C Düber; K J Klose; H Kopp; W Schmiedt
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Jul-Aug       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.